Hive Blockchain shares have been added to the portfolio.We currently feel that with the current resources available, this is the right move to be in the blockchain space. Hive Blockchain has the management experience, the existence in a growing market, and access to resources needed to build wealth for its stakeholders. The plan is to hold and likely add shares to the portfolio going forward.
From the company's website - Simply put, HIVE is a cryptocurrency mining firm. We validate
transactions on blockchain networks — like Ethereum — for rewards paid
in cryptocurrencies. Everyday HIVE earns new crypto coins which it can
monetize for revenue and cash flow. HIVE offers shareholders exposure to
the operating margins from cryptocurrency mining plus a growing
portfolio of coins.
KDK Fund looks to provide capital (financial, consulting, etc.) resources to companies and projects it deems are improving life's
existence. The portfolio also has an equity
stake in Crispr Therapeutics (post here), and Microvision (post here).
**All
posts on this blog are information and opinions only. They are not to
be considered recommendations to buy or sell any security. Please do
your due diligence first before trading and investing. Please direct all
questions and comments to the blog, kdkfund@gmail.com, or on
twitter @kdkfund.
No comments:
Post a Comment